671 related articles for article (PubMed ID: 22918031)
1. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.
Goines PE; Ashwood P
Neurotoxicol Teratol; 2013; 36():67-81. PubMed ID: 22918031
[TBL] [Abstract][Full Text] [Related]
2. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.
Suzuki K; Matsuzaki H; Iwata K; Kameno Y; Shimmura C; Kawai S; Yoshihara Y; Wakuda T; Takebayashi K; Takagai S; Matsumoto K; Tsuchiya KJ; Iwata Y; Nakamura K; Tsujii M; Sugiyama T; Mori N
PLoS One; 2011; 6(5):e20470. PubMed ID: 21647375
[TBL] [Abstract][Full Text] [Related]
3. Potential cytokine biomarkers in autism spectrum disorders.
Rose D; Ashwood P
Biomark Med; 2014; 8(9):1171-81. PubMed ID: 25402586
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.
Ashwood P; Krakowiak P; Hertz-Picciotto I; Hansen R; Pessah I; Van de Water J
Brain Behav Immun; 2011 Jan; 25(1):40-5. PubMed ID: 20705131
[TBL] [Abstract][Full Text] [Related]
5. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.
Rossignol DA; Frye RE
Mol Psychiatry; 2012 Apr; 17(4):389-401. PubMed ID: 22143005
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder.
Krakowiak P; Goines PE; Tancredi DJ; Ashwood P; Hansen RL; Hertz-Picciotto I; Van de Water J
Biol Psychiatry; 2017 Mar; 81(5):442-451. PubMed ID: 26392128
[TBL] [Abstract][Full Text] [Related]
7. Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study.
Jyonouchi H; Geng L; Streck DL; Toruner GA
J Neuroinflammation; 2012 Jan; 9():4. PubMed ID: 22226452
[TBL] [Abstract][Full Text] [Related]
8. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders.
Herbert MR
Curr Opin Neurol; 2010 Apr; 23(2):103-10. PubMed ID: 20087183
[TBL] [Abstract][Full Text] [Related]
9. Environmental toxicants and autism spectrum disorders: a systematic review.
Rossignol DA; Genuis SJ; Frye RE
Transl Psychiatry; 2014 Feb; 4(2):e360. PubMed ID: 24518398
[TBL] [Abstract][Full Text] [Related]
10. Autism spectrum disorders: from immunity to behavior.
Careaga M; Ashwood P
Methods Mol Biol; 2012; 934():219-40. PubMed ID: 22933149
[TBL] [Abstract][Full Text] [Related]
11. Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice.
Schwartzer JJ; Careaga M; Onore CE; Rushakoff JA; Berman RF; Ashwood P
Transl Psychiatry; 2013 Mar; 3(3):e240. PubMed ID: 23481627
[TBL] [Abstract][Full Text] [Related]
12. Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder.
Napolioni V; Ober-Reynolds B; Szelinger S; Corneveaux JJ; Pawlowski T; Ober-Reynolds S; Kirwan J; Persico AM; Melmed RD; Craig DW; Smith CJ; Huentelman MJ
J Neuroinflammation; 2013 Mar; 10():38. PubMed ID: 23497090
[TBL] [Abstract][Full Text] [Related]
13. Peripheral and central inflammation in autism spectrum disorders.
Depino AM
Mol Cell Neurosci; 2013 Mar; 53():69-76. PubMed ID: 23069728
[TBL] [Abstract][Full Text] [Related]
14. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.
Betancur C
Brain Res; 2011 Mar; 1380():42-77. PubMed ID: 21129364
[TBL] [Abstract][Full Text] [Related]
15. Immune dysregulation in autism spectrum disorder.
Noriega DB; Savelkoul HF
Eur J Pediatr; 2014 Jan; 173(1):33-43. PubMed ID: 24297668
[TBL] [Abstract][Full Text] [Related]
16. Immunological and autoimmune considerations of Autism Spectrum Disorders.
Gesundheit B; Rosenzweig JP; Naor D; Lerer B; Zachor DA; Procházka V; Melamed M; Kristt DA; Steinberg A; Shulman C; Hwang P; Koren G; Walfisch A; Passweg JR; Snowden JA; Tamouza R; Leboyer M; Farge-Bancel D; Ashwood P
J Autoimmun; 2013 Aug; 44():1-7. PubMed ID: 23867105
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?
Careaga M; Schwartzer J; Ashwood P
Brain Behav Immun; 2015 Jan; 43():11-6. PubMed ID: 24937468
[TBL] [Abstract][Full Text] [Related]
18. Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders.
Kim YS; Leventhal BL
Biol Psychiatry; 2015 Jan; 77(1):66-74. PubMed ID: 25483344
[TBL] [Abstract][Full Text] [Related]
19. Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders.
Abdallah MW; Larsen N; Grove J; Nørgaard-Pedersen B; Thorsen P; Mortensen EL; Hougaard DM
World J Biol Psychiatry; 2013 Sep; 14(7):528-38. PubMed ID: 22175527
[TBL] [Abstract][Full Text] [Related]
20. Immune dysregulation in autism spectrum disorder.
Hsiao EY
Int Rev Neurobiol; 2013; 113():269-302. PubMed ID: 24290389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
